Global PDX Models Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Published Report
  • Jul 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027.

Market Analysis and Insights  : Global PDX Models Market

PDX models market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.6% in the forecast period of 2020 to 2027 and is expected to reach USD 356,248.18 thousand by 2027 from USD 104,005.11 thousand in 2019. Wide adoption of PDX models in preclinical research & increasing demand for personalized medicine in PDX models are the major drivers which propelled the demand of the market in the forecast period.

In patient derived xenografts (PDX) models, the cancerous tumor or cells from the patients are transferred/ implanted into the immunodeficient rodents as mice or rat. PDX models are developed for the cancer research on the basis of expectations that these models have the capability to retain the tumor characteristics particularly for the patient derived orthotropic xenograft. Basically these models include the uninterrupted transfer of human disease sample into the mice.

PDX models are considered as an effective tool in the field of biomedical research, preclinical trials as both the species have similarities and these models have the capability of carrying the characteristics of the tumor, and also allow studying the tumor and its heterogeneity. They help in the evaluation of the tumor growth rate, life cycle of the tumor and growth rate of the tumor in different conditions. They also help in differentiating between the adult and childhood cancer. The adoption of the new therapies, patient specific therapies, and personalized medicine are all established by the use of PDX models in the basic cancer research and drug development.  

The PDX models market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Global PDX Models Market Scope and Market Size

PDX models market is segmented on the basis of type, tumor type, application, technique and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the global PDX models market is classified into mice models and rat models. In 2020, mice models segment is expected to dominate the market as researchers are increasingly using mice models more often than rats, because of mice superiority as genetic models. Further, smaller size of mice does offer some advantages, including requiring lower drug dosages, which makes them more cost-effective in drug development research.
  • On the basis of tumor type, the global PDX models market is classified into gastrointestinal tumor models, lung tumor models, haematological tumor models, gynecological tumor models, respiratory tumor models, urological tumor models and others. In 2020, gastrointestinal tumor models segment is expected to dominate the market due to increasing number of gastrointestinal tumor models along with increasing gastrointestinal tumor researches in academic & research institutions and contract research organizations.
  • On the basis of application, the global PDX models market is classified into preclinical drug development, precision medicine, co-clinical trials, and basic cancer research. In 2020, basic cancer research disease segment is expected to dominate the market due to increasing adoption of PDX models for basic cancer research. Basic cancer research is the characterization of cancer biology and to explore mechanisms which is involved for prediction or understanding of cancer. PDX models essentially provide importance in-vivo and ex-vivo evidence to aid basic studies of cancer, including tumor characterization, tumorigenesis, and metastasis.  
  • On the basis of technique, the global PDX models are segmented into heterotopic implantation and orthotropic implantation. In 2020, heterotopic implantation segment is expected to dominate the market as heterotopic implantation offers various advantages including easy methods of cell implantation, accurate monitoring of tumor size. Subcutaneous and intravenous PDX models, for solid tumors and leukemia, respectively, are the most widely used in cancer research. Moreover, heterotopic implantation is less technically challenging and time-consuming as compared to orthotropic implantation.
  • On the basis of end user, the global PDX models segment is segmented into academic & research organizations, contract research organizations, pharmaceutical and biotechnological companies and others. In 2020 academic & research organizations segment is expected to dominate the market as the PDX models usage are continuously increasing in academic & research organizations for basic cancer research particularly for characterization of cancer biology, tumorigenesis and metastasis.

PDX Models Market Country Level Analysis

The PDX models market is analysed and market size information is provided by country, type, tumour type, application, technique and end user.

The countries covered in the PDX models market report are the U.S., Canada, Mexico, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, rest of Europe, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and rest of Middle East & Africa.

The North America region is expected to dominate the PDX models market in the forecast period of 2020 to 2027 as usage of patient-derived xenograft (PDX) models is continuously increasing in the North America region from last few years due to the preclinical oncology work. Asia-Pacific is expected to grow with the highest CAGR due to increasing demand for personalized medicine in the region. The U.S. is leading the growth of the North America market due to increasing government initiatives for improving preclinical oncology work. Germany is dominating the European market with the increase in R&D activities in the pharmaceutical industries. China is leading the Asia-Pacific region because of increasing demand for personalized medicines in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Government and Private Sector is Creating New Opportunities for Players in the PDX Models Market 

PDX models market also provides you with detailed market analysis for every country growth in aesthetic industry with PDX models sales, impact of advancement in the PDX models and changes in regulatory scenarios with their support for the PDX models market. The data is available for historic period 2010 to 2018.  

Competitive Landscape and PDX Models Market Share Analysis

PDX models market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to PDX models market.

The major players covered in the report are Crown Bioscience Inc., THE JACKSON LABORATORY, Champions Oncology, Inc., Charles River Laboratories, Wuxi AppTec, Oncodesign, Aragen Bioscience, Biocytogen, Bioduro, BioModels, Creative Animodel, Covance Inc., EPO Berlin-Buch GmbH, EUROPDX., Explora BioLabs, Hera BioLabs, Horizon discovery Ltd., Pharmatest Services, Urospehere SAS, Xentech, Xenopat among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the PDX models market.

For instance,

  • In October 2019, Crown Bioscience Inc. announced strategic collaboration with NEXT Oncology for focusing more on preclinical drug development by providing new relevant models. This collaboration has helped the company to serve more customers as they have the global presence worldwide and could generate more revenue. 
  • In April 2018, THE JACKSON LABORATORY and European Bioinformatics Institute created first cancer research portal for PDX models. By using these models, researchers can understand better drug reaction on the patient which is patient specific too. This has provided wide variety of the models at one place quickly.  

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the PDX models market which also provides the benefit for organisation to improve their offering for PDX models.

Customization Available: Global PDX Models Market  

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES GLOBAL PDX MODELS MARKET

TABLE 1 GLOBAL PDX MODELS MARKET, BY TYPE, 2016– 2025, (USD MILLION)

TABLE 2 GLOBAL MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 3 GLOBAL RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 4 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE, 2016– 2025 (USD MILLION)

TABLE 5 GLOBAL GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 6 GLOBAL GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 7 GLOBAL RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 8 GLOBAL UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 9 GLOBAL HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 10 GLOBAL OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 11 GLOBAL PDX MODELS MARKET, BY APPLICATION, 2016– 2025 (USD MILLION)

TABLE 12 GLOBAL PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 13 GLOBAL BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 14 GLOBAL PDX MODELS MARKET, BY END USER, 2016– 2025, (USD MILLION)

TABLE 15 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 16 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 17 GLOBAL ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 18 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY, 2016 – 2025, (USD MILLION)

TABLE 19 NORTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016 – 2025, (USD MILLION)

TABLE 20 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 21 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 22 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 23 NORTH AMERICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 24 U.S. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 25 U.S. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 26 U.S. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 27 U.S. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 28 CANADA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 29 CANADA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 30 CANADA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 31 CANADA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 32 MEXICO PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 33 MEXICO PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 34 MEXICO PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 35 MEXICO PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 36 EUROPE PDX MODELS MARKET, BY COUNTRY , 2016 – 2025 (USD MILLION)

TABLE 37 EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 38 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 39 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 40 EUROPE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 41 GERMANY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 42 GERMANY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 43 GERMANY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 44 GERMANY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 45 FRANCE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 46 FRANCE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 47 FRANCE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 48 FRANCE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 49 U.K. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 50 U.K. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 51 U.K. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 52 U.K. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 53 ITALY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 54 ITALY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 55 ITALY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 56 ITALY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 57 SPAIN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 58 SPAIN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 59 SPAIN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 60 SPAIN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 61 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 62 SWITZERLAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 63 SWITZERLAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 64 SWITZERLAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 65 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 66 NETHERLANDS PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 67 NETHERLANDS PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 68 NETHERLANDS PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 69 TURKEY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 70 TURKEY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 71 TURKEY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 72 TURKEY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 73 BELGIUM PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 74 BELGIUM PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 75 BELGIUM PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 76 BELGIUM PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 77 RUSSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 78 RUSSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 79 RUSSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 80 RUSSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 81 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 82 ASIA PACIFIC PDX MODELS MARKET, BY COUNTRY , 2016 – 2025, (USD MILLION)

TABLE 83 ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 84 ASIA PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 85 ASIA PACIFIC PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 86 ASIA PACIFIC PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 87 JAPAN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 88 JAPAN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 89 JAPAN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 90 JAPAN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 91 CHINA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 92 CHINA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 93 CHINA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 94 CHINA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 95 INDIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 96 INDIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 97 INDIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 98 INDIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 99 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 100 SOUTH KOREA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 101 SOUTH KOREA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 102 SOUTH KOREA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 103 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 104 AUSTRALIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 105 AUSTRALIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 106 AUSTRALIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 107 SINGAPORE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 108 SINGAPORE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 109 SINGAPORE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 110 SINGAPORE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 111 THAILAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 112 THAILAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 113 THAILAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 114 THAILAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 115 MALAYSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 116 MALAYSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 117 MALAYSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 118 MALAYSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 119 INDONESIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 120 INDONESIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 121 INDONESIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 122 INDONESIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 123 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 124 PHILIPPINES PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 125 PHILIPPINES PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 126 PHILIPPINES PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 127 REST OF ASIA PACIFIC PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 128 SOUTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)

TABLE 129 SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 130 SOUTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 131 SOUTH AMERICA IN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 132 SOUTH AMERICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 133 BRAZIL PDX MODELS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 134 BRAZIL PDX MODEL MARKET, BY TUMOR TYPE, 2016 – 2025 (USD MILLION)

TABLE 135 BRAZIL PDX MODELS MARKET, BY APPLICATION , 2016 - 2025 (USD MILLION)

TABLE 136 BRAZIL PDX MODEL MARKET, BY END USER, 2016 - 2025 (USD MILLION)

TABLE 137 REST OF SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2016-2025 (USD MILLION)

TABLE 138 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)

TABLE 139 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 140 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 141 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 142 MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 143 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 144 SOUTH AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 145 SOUTH AFRICA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 146 SOUTH AFRICA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 147 REST OF MIDDLE EAST AND AFRICA PDX MODELS MARKET, BY TYPE, 2016-2025, (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19